Henna encodes phenylalanine hydroxylase isoforms involved in aromatic amino-acid metabolism. The native 178-residue PD product retains the C-terminal iron-ligand region but lacks much of the catalytic scaffold, including the substrate-responsive loop and pterin-binding architecture. These losses contradict conventional pteridine-dependent hydroxylase activity. Its metal-binding capacity and possible noncatalytic physiological role remain unresolved.
Summary: PD lacks the conserved substrate/cofactor architecture required for the hydroxylase reaction.
Reason: Human PAH structural-site mapping through a full-length Hn positive control shows that the substrate-responsive loop 131β155, pterin-binding loop 245β250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions but are entirely absent from PD. Mutagenesis establishes the importance of the cofactor-stacking site, and the deleted domain segment encompasses substantially more than that residue. Retained iron ligands cannot replace the missing substrate/pteridine reaction-center architecture. This directly contradicts transfer of the conventional enzyme activity to the short product; it does not deny possible metal binding or an unrelated noncatalytic role.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: PD lacks the conserved substrate/cofactor architecture required for the hydroxylase reaction.
Reason: Human PAH structural-site mapping through a full-length Hn positive control shows that the substrate-responsive loop 131β155, pterin-binding loop 245β250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions but are entirely absent from PD. Mutagenesis establishes the importance of the cofactor-stacking site, and the deleted domain segment encompasses substantially more than that residue. Retained iron ligands cannot replace the missing substrate/pteridine reaction-center architecture. This directly contradicts transfer of the conventional enzyme activity to the short product; it does not deny possible metal binding or an unrelated noncatalytic role.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: All three iron-coordinating residue identities are retained, but metal binding requires their correct spatial assembly in a folded pocket.
Reason: All three iron-coordinating residue identities are retained, but metal binding requires their correct spatial assembly in a folded pocket. The large catalytic-domain truncation prevents establishing that geometry from sequence matches alone. Iron binding is plausible but not validated for native PD.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: Phenylalanine hydroxylation contributes to aromatic-amino-acid and tyrosine metabolism in full-length Hn.
Reason: Phenylalanine hydroxylation contributes to aromatic-amino-acid and tyrosine metabolism in full-length Hn. The short PD isoform lacks much of the catalytic scaffold, and neither catalytic activity nor a noncatalytic contribution to the process is established. Its gene origin supports a hypothesis, not a demonstrated isoform-level process role.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: Phenylalanine hydroxylation contributes to aromatic-amino-acid and tyrosine metabolism in full-length Hn.
Reason: Phenylalanine hydroxylation contributes to aromatic-amino-acid and tyrosine metabolism in full-length Hn. The short PD isoform lacks much of the catalytic scaffold, and neither catalytic activity nor a noncatalytic contribution to the process is established. Its gene origin supports a hypothesis, not a demonstrated isoform-level process role.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
GO:0016714 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen
IEA GO_REF:0000002
REMOVE
Summary: PD lacks the conserved substrate/cofactor architecture required for the hydroxylase reaction.
Reason: Human PAH structural-site mapping through a full-length Hn positive control shows that the substrate-responsive loop 131β155, pterin-binding loop 245β250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions but are entirely absent from PD. Mutagenesis establishes the importance of the cofactor-stacking site, and the deleted domain segment encompasses substantially more than that residue. Retained iron ligands cannot replace the missing substrate/pteridine reaction-center architecture. This directly contradicts transfer of the conventional enzyme activity to the short product; it does not deny possible metal binding or an unrelated noncatalytic role.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.
Review rationale: The native 178-residue Hn-PD isoform lacks substrate/cofactor architecture required for conventional hydroxylase chemistry, as established by mapping human PAH structural sites through full-length Hn. This refutes intrinsic hydroxylase activity but does not exclude a noncatalytic or regulatory contribution to aromatic amino acid metabolism. No evidence establishes such a process contribution by PD, so the broad process prediction remains UNC.
file:DROME/Hn/Hn-bioinformatics/RESULTS.md: "The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD."
GO:0016714 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygenGO_MF
Review rationale: The exact native PD isoform lacks the PAH substrate-responsive loop, pterin-binding loop and cofactor-stacking Phe site, established by human-to-full-length-Hn mapping and their absence from PD. Primary structural and mutagenesis studies identify these as reaction-center features; only 149 of 307 aligned catalytic-domain residues remain. The three iron ligands and Glu cofactor contact are retained, but cannot supply the missing substrate/cofactor architecture. This refutes transfer of conventional pteridine-dependent hydroxylase chemistry, despite overlap with an existing electronic annotation. The conclusion concerns intrinsic catalysis, not all possible process participation or a supposed error in the native transcript sequence.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md: "The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD."
PMID:10694386: "Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH."
PMID:12126628: "The largest change occurs in the loop region comprising residues 131-155"